SOM News: SomnoMed's North America Q1 revenue growth leads the way - 29th Oct 2022, 6:06am

[annb0t]

PLANO, Texas, Oct. 28, 2022 /PRNewswire/ -- SomnoMed Limited (ASX "SOM", or the Company), a leading company in the provision of oral appliance treatment solutions for sleep-related breathing disorders and obstructive sleep apnea ('OSA'), is pleased to provide its quarterly activities report for the period ended 30 September 2022 (Q1 FY23). SomnoMed® is the world’s largest supplier of oral sleep apnea devices, operating in 28 countries. (PRNewsfoto/SomnoMed)

Financial Highlights

Q1 FY23...

>>> Read more: SomnoMed's North America Q1 revenue growth leads the way